Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Issues Quarterly Earnings Results, Beats Estimates By $0.09 EPS

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) released its quarterly earnings data on Friday. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.09, Zacks reports. The business had revenue of $966.53 million for the quarter, compared to analysts’ expectations of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 11.90% and a net margin of 39.53%.

Shionogi & Co., Ltd. Unsponsored ADR Stock Performance

Shares of OTCMKTS:SGIOY traded up $0.10 during midday trading on Friday, reaching $10.22. 50,568 shares of the company’s stock traded hands, compared to its average volume of 143,744. Shionogi & Co., Ltd. Unsponsored ADR has a one year low of $6.74 and a one year high of $10.30. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.74 and a current ratio of 6.44. The stock has a 50 day moving average of $9.01 and a 200 day moving average of $8.72. The company has a market cap of $17.39 billion, a price-to-earnings ratio of 15.97, a P/E/G ratio of 2.10 and a beta of 0.19.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.